Cite
Mazzilli S, Dattola A, Criscuolo AA, et al. Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy. Dermatol Pract Concept. 2021;11(2):e2021011doi: 10.5826/dpc.1102a11.
Mazzilli, S., Dattola, A., Criscuolo, A. A., Cosio, T., Bianchi, L., Campione, E., Di Prete, M., & Botti, E. (2021). Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy. Dermatology practical & conceptual, 11(2), e2021011. https://doi.org/10.5826/dpc.1102a11
Mazzilli, Sara, et al. "Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy." Dermatology practical & conceptual vol. 11,2 (2021): e2021011. doi: https://doi.org/10.5826/dpc.1102a11
Mazzilli S, Dattola A, Criscuolo AA, Cosio T, Bianchi L, Campione E, Di Prete M, Botti E. Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy. Dermatol Pract Concept. 2021 Mar 08;11(2):e2021011. doi: 10.5826/dpc.1102a11. eCollection 2021 Mar. PMID: 33747624; PMCID: PMC7943228.
Copy
Download .nbib
